NCT03720613 2025-02-12Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced ConstipationBioDelivery Sciences InternationalRecruiting34,532 enrolled
NCT06539169 2024-11-14FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesxCuresRecruiting1,000 enrolled
NCT05579444 2023-12-15Systems Biology of Gastrointestinal and Related DiseasesViomeTerminated17 enrolled
NCT04967209 2023-03-31Investigation of a Digital Healthy Habits Program for Individuals With Breast CancerNoom Inc.Completed30 enrolled
NCT02921802 2022-06-14A Study of Special Use Results Surveillance of Revlimid 5mg CapsulesCelgeneCompleted4,626 enrolled
NCT02922543 2022-06-14A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of UseCelgeneCompleted361 enrolled
NCT01928953 2015-07-08Longitudinal Study of Patients With Opioid-Induced ConstipationAstraZenecaCompleted520 enrolled